Inflammatory abnormalities underlie a large variety of human diseases. Tissue damage resulting from impaired control of the complex system of immune cells and mediators can also play a role in autoimmunity and non-immune diseases such as cancer and atherosclerosis.
At Cerba Research, global access to demographically rich data and industry-leading laboratories drives the development of more advanced biomarker strategies to help characterize the mechanisms that account for inflammatory and autoimmune diseases — and identify novel targets for therapeutic intervention.
32,828 Patients screened
74 Sites
66 Countries
Our Inflammatory Disease Trials
Our Autoimmune Disease Trials
64% of our autoimmune disease trials have resulted in FDA-approved drugs.
Inflammation
Enhance your research in inflammatory conditions with our broad complement of test services and research assistance related to:
- Biomarkers
- Genetics
- Immune monitoring
- Allergies and respiratory disorders
- Autoimmune diseases
- Pathogenesis
Autoimmune diseases
Investigations into autoimmunity benefit from a multifaceted approach.
Genetic Testing/NGS
Along with infections and other exposures, genes play a significant role in disease development
Diagnosis & development
Tissue diagnosis and routine testing register pathology and the course of the disease
Immune monitoring
Gauge response to treatment by following up on the status of immune cells via flow cytometry
Biomarker Testing
Develop and follow serum markers for both diagnosis and prognosis of autoimmune diseases
For other relevant methodologies, please see our immuno-oncology offerings.
